THE INTERPLAY BETWEEN ANTI-CD20 THERAPEUTIC ANTIBODIES AND "MEMORY" NATURAL KILLER CELLS

被引：0
|
作者：
Capuano, Cristina [1 ]
Battella, Simone [2 ]
Pighi, Chiara [2 ]
Franchitti, Lavinia [2 ]
Santoni, Angela [2 ]
Galandrini, Ricciarda [1 ]
Palmieri, Gabriella [1 ]
机构：
[1] Sapienza Univ, Dept Expt Med, Rome, Italy
[2] Sapienza Univ, Dept Mol Med, Lab Pasteur Italia Fdn Cenci Bolognetti, Rome, Italy
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2017年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
562
引用
收藏
页码：21 / 22
页数：2
相关论文
共 50 条
  • [1] CHARACTERIZATION OF A PATIENTS' ANTIBODIES TO THE ANTI-CD20 THERAPEUTIC RITUXIMAB
    Mahadik, Younis
    Young, Stephen
    Morgan, Matthew
    Gordon, Caroline
    Harper, Lorraine
    [J]. RHEUMATOLOGY, 2012, 51 : 142 - 143
  • [2] Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
    Kohrt, Holbrook E.
    Thielens, Ariane
    Marabelle, Aurelien
    Sagiv-Barfi, Idit
    Sola, Caroline
    Chanuc, Fabien
    Fuseri, Nicolas
    Bonnafous, Cecile
    Czerwinski, Debra
    Rajapaksa, Amanda
    Waller, Erin
    Ugolini, Sophie
    Vivier, Eric
    Romagne, Francois
    Levy, Ronald
    Blery, Mathieu
    Andre, Pascale
    [J]. BLOOD, 2014, 123 (05) : 678 - 686
  • [3] MODULATION OF CD20 EXPRESSION ON B CELLS BY ANTI-CD20 ANTIBODIES
    Bellintani, Elaine C.
    de Marco, Renato
    Fantini, Renata
    Valim, Tiago
    Macedo, Denise
    Miyamoto, Yuriko
    Temin, Julia
    Gerbase-DeLima, Maria
    [J]. HUMAN IMMUNOLOGY, 2016, 77 : 138 - 138
  • [4] BLOCKING B-CELLS (ANTI-CD20/ANTI-CD20)
    Isenberg, David A.
    [J]. RHEUMATOLOGY, 2015, 54 : 1 - 1
  • [5] Cross-Reactivity of Antibodies to Rituximab with Other Therapeutic Anti-CD20 Antibodies
    Rispens, Theo
    Kuijpers, Taco W.
    Killestein, Joep
    van Kempen, Zoe L. E.
    Bloem, Karien
    [J]. JOURNAL OF IMMUNOLOGY, 2024, 212 (04): : 529 - 533
  • [6] Salinomycin expands the cytotoxicity of both anti-CD20 monoclonal antibodies and natural killer cells towards non-Hodgkin lymphomas
    Zerrouqi, Abdessamad
    Miazek-Zapala, Nina
    Torun, Anna
    Zapala, Piotr
    Golab, Jakub
    Winiarska, Magdalena
    Pyrzynska, Beata
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [7] Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming
    Capuano, Cristina
    Battella, Simone
    Pighi, Chiara
    Franchitti, Lavinia
    Turriziani, Ombretta
    Morrone, Stefania
    Santoni, Angela
    Galandrini, Ricciarda
    Palmieri, Gabriella
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [8] Is there a role for anti-CD20 antibodies in CLL?
    Shah, Harsh R.
    Stephens, Deborah M.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 68 - 75
  • [9] Clinical applications of anti-CD20 antibodies
    Gopal, AK
    Press, OW
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1999, 134 (05): : 445 - 450
  • [10] Anti-CD20 monoclonal antibodies: Beyond B-cells
    Avivi, Irit
    Stroopinsky, Dina
    Katz, Tamar
    [J]. BLOOD REVIEWS, 2013, 27 (05) : 217 - 223
12345